fluconazole has been researched along with Chronic Liver Failure in 1 studies
Fluconazole: Triazole antifungal agent that is used to treat oropharyngeal CANDIDIASIS and cryptococcal MENINGITIS in AIDS.
fluconazole : A member of the class of triazoles that is propan-2-ol substituted at position 1 and 3 by 1H-1,2,4-triazol-1-yl groups and at position 2 by a 2,4-difluorophenyl group. It is an antifungal drug used for the treatment of mucosal candidiasis and for systemic infections including systemic candidiasis, coccidioidomycosis, and cryptococcosis.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Although invasive fungal infections (IFIs) contribute to substantial morbidity and mortality in liver transplant recipients, only a few randomized studies analyzed the results of antifungal prophylaxis with echinocandins." | 2.94 | A Multicenter, Randomized, Open-Label Study to Compare Micafungin with Fluconazole in the Prophylaxis of Invasive Fungal Infections in Living-Donor Liver Transplant Recipients. ( Choi, DL; Joh, JW; Kang, WH; Kim, JD; Kim, JM; Kim, MS; Kwon, CHD; Lee, KW; Lee, SG; Song, GW; Suh, KS; Yi, NJ, 2020) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kang, WH | 1 |
| Song, GW | 1 |
| Lee, SG | 1 |
| Suh, KS | 1 |
| Lee, KW | 1 |
| Yi, NJ | 1 |
| Joh, JW | 1 |
| Kwon, CHD | 1 |
| Kim, JM | 1 |
| Choi, DL | 1 |
| Kim, JD | 1 |
| Kim, MS | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Randomized, Open Label, Non-inferiority Study of Micafungin Versus Fluconazole for the Korean Prevention of Invasive Fungal Disease in Living Donor Liver Transplant Recipients[NCT01974375] | Phase 3 | 172 participants (Anticipated) | Interventional | 2012-08-31 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for fluconazole and Chronic Liver Failure
| Article | Year |
|---|---|
A Multicenter, Randomized, Open-Label Study to Compare Micafungin with Fluconazole in the Prophylaxis of Invasive Fungal Infections in Living-Donor Liver Transplant Recipients.
Topics: Antifungal Agents; End Stage Liver Disease; Fluconazole; Hematopoietic Stem Cell Transplantation; Hu | 2020 |